KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)
$8.93 0.11 (1.2472%)
Analysed KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) News Sources
Kazia (KZIA) Raises Approximately $40M in Gross Proceeds and Expands Paxalisib. Is the Capital Base Stronger than the Clinical Evidence?
09-09-2026
yahoo.com
Bank of New York Mellon Corporation (BNY) Lost A Depositary Mandate
19-09-2026
yahoo.com
Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering
31-08-2026
yahoo.com
Kazia closes oversubscribed offering to fund paxalisib’s clinical development
01-09-2026
hospitalmanagement.net
Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
01-09-2026
yahoo.com
Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy
01-09-2026
yahoo.com
Kazia Therapeutics Reports Preclinical Tumor Reduction in Colorectal Cancer Study
01-09-2026
yahoo.com
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
09-09-2026
yahoo.com
Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
22-09-2026
yahoo.com
What is the current price of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)?
The current price of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) is $8.93.
KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) absolute price change since previous trading day?
The absolute price change of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) since the previous trading day is $0.11.
KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) percentage price change since previous trading day?
The percentage price change of KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) since the previous trading day is 1.2472%.
What is the most recent average sentiment score for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)?
The most recent average sentiment score for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)?
The most recent sentiment for KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ) is .
SEC-8K** Filing Available For KAZIA THERAPEUTICS-SPON ADR (KZIA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.